Engineers Gate Manager LP reduced its position in Sabra Health Care REIT by 1,513,777 shares (valued at ~$28.06 million), bringing the stake to 1.02% of the fund's assets. The sale reflects investor focus on healthcare REIT rental income sustainability, particularly as operators face challenges from Medicare/Medicaid reimbursement, labor costs, and occupancy trends.

Engineers Gate Manager LP increased its stake in Agree Realty (ADC) by 1,144,617 shares, bringing its total position to $85.16 million. The investment represents 1.01% of the fund's assets under management. ADC shares have appreciated 13.4% over the past year, outperforming the S&P 500.

Sabra Health Care REIT exceeded Q2 2025 analyst expectations with strong performance in managed senior housing, reporting normalized FFO of $0.37 per share and revenue of $189.15 million, representing a 7.4% year-over-year increase.

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Evaluate the expected performance of Sabra (SBRA) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners said if you are looking for a stock that’s on the verge of breaking out, Deere & Company (NYSE: DE). On March 25, Deere & Company said former Eastman Chemical Company executive, Kellye Walker, will join its leadership team as senior vice president, chief legal officer and worldwide public affairs, effective April 29. Stephen Weiss of Short Hills Capital Partners picked ASML Holding N.V. (NASDAQ: ASML), saying that ...

The headline numbers for Sabra (SBRA) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Sabra (SBRA) delivered FFO and revenue surprises of -2.94% and 0.05%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Beyond analysts' top -and-bottom-line estimates for Sabra (SBRA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.

National Health Investors reported strong Q4-2023 results, beating revenue and funds from operations estimates. Learn why NHI stock is a Hold.

Alexander's (ALX) delivered FFO and revenue surprises of -16.13% and 13.60%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management said Sabra Health Care REIT, Inc. (NASDAQ: SBRA) has a 9% yield and 5% earnings growth. Deutsche Bank analyst Omotayo Okusanya initiated coverage on Sabra Health Care REIT with a Buy rating and announced a price target of $21. Sabra Health Care recently named Jessica Flores as executive vice president and chief accounting officer. Josh Brown of Ritholtz Wealth Management picked The Goldman Sachs ...